FDA Adverse Event Malfunction Summary report: N

T:SLIM X2 INSULIN PUMP WITH INTEROPERABLE TECHNOLOGY

MDR report key: 10101879 · Received May 29, 2020

Report

Report Number
3013756811-2020-54878
Event Type
Malfunction
Date Received
May 29, 2020
Date of Event
May 6, 2020
Report Date
May 29, 2020
Manufacturer
TANDEM DIABETES CARE
Product Code
QFG
UDI-DI
00850006613205
PMA / PMN Number
DEN180058
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UT, US
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 0

IT WAS REPORTED THAT MULTIPLE OCCLUSION ALARMS OCCURRED. CUSTOMER REPORTED USING APIDRA INSULIN. CUSTOMER CHANGED PUMP SUPPLIES TO ADDRESS THE OCCLUSION ALARMS AND RESUMED INSULIN. OCCLUSION RECURRED AND CUSTOMER REVERTED TO AN ALTERNATE PUMP FOR INSULIN THERAPY. CUSTOMER'S BLOOD GLUCOSE WAS 270 MG/DL.

Additional Manufacturer Narrative · 1

THE T:SLIM X2 WITH CIQ TECHNOLOGY USER GUIDE STATES: DO NOT USE ANY OTHER INSULIN WITH YOUR SYSTEM OTHER THAN U-100 HUMALOG OR U-100 NOVOLOG. ONLY HUMALOG AND NOVOLOG HAVE BEEN TESTED AND FOUND TO BE COMPATIBLE FOR USE IN THE SYSTEM. USE OF INSULIN WITH LESSER OR GREATER CONCENTRATION CAN RESULT IN UNDER DELIVERY OR OVER DELIVERY OF INSULIN. THIS CAN CAUSE VERY HIGH OR A VERY LOW BLOOD GLUCOSE. NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT MULTIPLE OCCLUSION ALARMS OCCURRED. CUSTOMER REPORTED USING APIDRA INSULIN. TANDEM CUSTOMER TECHNICAL SUPPORT INFORMED CUSTOMER THAT APIDRA IS OFF LABEL PER THE USER GUIDE. CUSTOMER USED OLD PUMP THROUGH TODAY. CUSTOMER CHANGED PUMP SUPPLIES TO ADDRESS THE OCCLUSION ALARMS AND SUCCESSFULLY RESUMED INSULIN. CUSTOMER'S BLOOD GLUCOSE WAS 270 MG/DL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
565644 T:SLIM X2 INSULIN PUMP WITH INTEROPERABLE TECHNOLOGY ALTERNATE CONTROLLER ENABLED INFUSION PUMP QFG TANDEM DIABETES CARE 1002717 00850006613205

Patients

Seq Age Sex Outcome Treatment
1 20 YR